{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Annovis Bio, Inc."},"Symbol":{"label":"Symbol","value":"ANVS"},"Address":{"label":"Address","value":"1055 WESTLAKES DRIVE,SUITE 300, BERWYN, Pennsylvania, 19312, United States"},"Phone":{"label":"Phone","value":"+1 610 727-3913"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301."},"CompanyUrl":{"label":"Company Url","value":"https://www.annovisbio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Cheng Fang","title":"Senior Vice President-Research & Development"},{"name":"Maria-Luisa Maccecchini","title":"President, Chief Executive Officer & Director"},{"name":"Melissa Gaines","title":"Senior Vice President-Clinical Operations"},{"name":"Sarah MacCallum","title":"Senior Clinical Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}